moatshark My

All holdings

Cardinal Health

CAH

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
3
In their latest 13F (Q3 2026)
See who
Value held
$3.6m
Combined value at quarter end
Last quarter
1 bought
0 sold or trimmed
Price at Q2 ’26 end
$237.56
+12.4% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

+12.4%Q3 ’24
+7.0%Q4 ’24
+16.5%Q1 ’25
+21.9%Q2 ’25
-6.6%Q3 ’25
+30.9%Q4 ’25
+2.8%Q1 ’26
+12.4%Q2 ’26
Q3 ’24: +12.4%; Q4 ’24: +7.0%; Q1 ’25: +16.5%; Q2 ’25: +21.9%; Q3 ’25: -6.6%; Q4 ’25: +30.9%; Q1 ’26: +2.8%; Q2 ’26: +12.4%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

3Q4 ’23
3Q1 ’24
3Q2 ’24
3Q3 ’24
2Q4 ’24
2Q1 ’25
3Q2 ’25
3Q3 ’25
3Q4 ’25
3Q1 ’26
3Q2 ’26
0Q3 ’26
Q4 ’23: 3; Q1 ’24: 3; Q2 ’24: 3; Q3 ’24: 3; Q4 ’24: 2; Q1 ’25: 2; Q2 ’25: 3; Q3 ’25: 3; Q4 ’25: 3; Q1 ’26: 3; Q2 ’26: 3; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Cardinal Health.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Cardinal Health
Southeastern Asset Management0.1%$1.7m$1.7mUnchanged20 qtrs
First Eagle Investment Management0.0%$1.4m$1.4mAdded +1.7%18 qtrs
Mairs & Power0.0%$504k$504kUnchanged5 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of Cardinal Health
Bought or soldFiling
19 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold16,187$237.23$3.8mForm 4
19 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold6,731$236.46$1.6mForm 4
19 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold6,244$237.88$1.5mForm 4
19 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold6,206$233.22$1.4mForm 4
19 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold5,704$235.34$1.3mForm 4
19 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold3,457$234.29$810kForm 4
19 Aug 2026Scherer Mary C.Chief Accounting Officer▼ Sold2,202$237.39$523kForm 4
19 Aug 2026Scherer Mary C.Chief Accounting Officer▼ Sold100$237.40$24kForm 4
18 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold29,915$235.51$7.0mForm 4
18 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold21,407$234.56$5.0mForm 4
18 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold16,208$236.54$3.8mForm 4
18 Aug 2026Alt Aaron EChief Financial Officer▼ Sold13,685$236.58$3.2mForm 4
18 Aug 2026Alt Aaron EChief Financial Officer▼ Sold12,972$237.26$3.1mForm 4
18 Aug 2026Mason Stephen MCEO, GMPD Segment▼ Sold12,829$237.26$3.0mForm 4
18 Aug 2026Hollar Jason M.Chief Executive Officer▼ Sold12,470$237.25$3.0mForm 4
18 Aug 2026Alt Aaron EChief Financial Officer▼ Sold12,228$235.54$2.9mForm 4
18 Aug 2026Mayer Jessica LChief Legal/Compliance Officer▼ Sold10,864$237.31$2.6mForm 4
18 Aug 2026Mason Stephen MCEO, GMPD Segment▼ Sold10,876$236.50$2.6mForm 4
18 Aug 2026Mayer Jessica LChief Legal/Compliance Officer▼ Sold10,246$235.51$2.4mForm 4
18 Aug 2026Mason Stephen MCEO, GMPD Segment▼ Sold8,195$235.62$1.9mForm 4

About the company

Sector
Health care · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Incorporated in
Ohio
Financial year ends
30 June
Shares outstanding
233m at 31 Jul 2026
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$91bnJun ’14
$122bnJun ’16
$137bnJun ’18
$153bnJun ’20
$181bnJun ’22
$227bnJun ’24
$254bnJun ’26
Jun ’13: $101bn; Jun ’14: $91bn; Jun ’15: $103bn; Jun ’16: $122bn; Jun ’17: $130bn; Jun ’18: $137bn; Jun ’19: $146bn; Jun ’20: $153bn; Jun ’21: $162bn; Jun ’22: $181bn; Jun ’23: $205bn; Jun ’24: $227bn; Jun ’25: $223bn; Jun ’26: $254bn
Cardinal Health revenue and net income by year
YearRevenueNet income
Year to Jun 2026$254bn$1.7bn
Year to Jun 2025$223bn$1.6bn
Year to Jun 2024$227bn$852m
Year to Jun 2023$205bn$330m
Year to Jun 2022$181bn−$938m
Year to Jun 2021$162bn$611m
Year to Jun 2020$153bn−$3.7bn
Year to Jun 2019$146bn$1.4bn
Year to Jun 2018$137bn$256m
Year to Jun 2017$130bn$1.3bn
Year to Jun 2016$122bn$1.4bn
Year to Jun 2015$103bn$1.2bn
Year to Jun 2014$91bn$1.2bn
Year to Jun 2013$101bn$334m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.